Ankit agrawal Studied a key biological challenge related to translation efficiency for most modified mRNA based drugtechnologies in collaboration with Moderna Therapeutics, $500,000 grant. He has described a paradigm changing model for transfer RNA processing in bacteria. He is reviewer board of plos one,RNA biology. He has teaching experience in Introductory Applied Microbiology laboratory